- TWD12.27bn
- TWD11.67bn
- TWD1.25bn
- 100
- 25
- 51
- 65
2019 December 31st | C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 570 | 706 | 917 | 1,035 | 1,251 |
Cost of Revenue | |||||
Gross Profit | 311 | 385 | 495 | 565 | 696 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 388 | 500 | 604 | 670 | 785 |
Operating Profit | 182 | 207 | 312 | 365 | 466 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 168 | 197 | 305 | 322 | 531 |
Provision for Income Taxes | |||||
Net Income After Taxes | 141 | 164 | 247 | 249 | 437 |
Net Income Before Extraordinary Items | |||||
Net Income | 141 | 164 | 247 | 249 | 437 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 141 | 164 | 247 | 249 | 437 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.32 | 2.69 | 3.63 | 3.33 | 5.85 |
Dividends per Share |